Contact

Please let us know how we can help you!

+43 3144 706
pharma@stoelzle.com

Contact form

Please, add your first item to the enquiry basket

Product has been added
View enquiry basket
Close window
en

Veterinary Medicine

The veterinary pharmaceuticals market consists of veterinary medicines which are used for both pet animals (companion animals) and farm animals (livestock).

Veterinary medicine includes drugs and vaccines:

  • Antibiotics
  • Parasiticides
  • Anti-inflammatory
  • Medicated feed additives

Rising market

Every year the global veterinary market is growing by 7.4%, because:

  • Growing number of chronic diseases
  • Increasing adoption of pet animals
  • Incremented use of drugs
  • Increased consumption of meat
  • Mandatory animal vaccinations

Segmentation of the global veterinary medicine market

The global veterinary medicine market size was estimated at USD 29.2 billion in 2020 and is expected to expand at a compound annual growth rate (CAGR) of 7.4 % from 2021 to 2028.

The market can be segmented by the following categories:

  • Animal type: pet animals or livestock
  • Product type: drugs and vaccines
  • Application type: oral or parenteral
  • Distribution channel: retail stores, (online-)pharmacies, veterinary hospitals
  • Region or country (from more to less relevant): North America, Europe, Asia-Pacific, Middle-East, Africa and South America.

The most important geographic areas for veterinary markets are surely North America and Europe. In 2019 Europe for instance had 29.5 % of the market share.

Back to top ↑

Main drivers of the veterinary medicine market

Generally speaking, there are five drivers mainly responsible for the growth of the veterinary medicine market:

  • Growing number of chronic diseases among animals
  • Increasing adoption of pet animalsI
  • Incremented use of drugs by pet and livestock animal owners
  • Increased consumption of meat and animal-based products due to higher population numbers
  • Mandatory animal vaccinations

Incrementing number of infectious diseases among animals

The growing number of diseases in animals affect humans as well, it is proven that three out of four new infectious illnesses in humans are spread by animals. Hence, there is a high interest in prematurely curing such infections with drugs.

Humanization of pet animals

Moreover, pet adoptions are rising. It is not surprising that this trend is mainly responsible for the market growth of veterinary medicine. People who commit to a companion animal have a high interest in its care and disease treatment.

In other words, the human-animal bond significantly gained importance and pets are now part of the family. This new trend of humanization of pets leads to a higher spending on pet care. Pet parents want to ensure that their pets are in good mental, physical, and emotional conditions.

This strong relationship between owner and pet is also visible in the trend of organic pet care. Companion animals are treated with essential oils, CBD, homeopathy or natural essences used for preventing or treating diseases and ensure health and well-being.

Back to top ↑

Consequences of COVID-19

Interestingly, the coronavirus (COVID-19) pandemic has led to an unprecedented rise in pet ownership. Many animal shelters reported, that there was a high number of retrievals during the lockdowns. In fact, according to the American Pet Products Association (APPA), pet ownership in the U.S. increased to 70% of the US households and similar phenomena could be noticed in Europe.

Rising meat consumption

According to Grandview research report, the global livestock population has been experiencing rapid growth. Increasing consumption of meat and animal-based products are boosting the demand for veterinary pharmaceuticals and vaccines for animals.

Furthermore, an increasing number of countries release laws for mandatory animal vaccinations. This circumstance again contributes to the market growth of veterinary medicine.

Back to top ↑

Picture showing flint and amber injection bottles in different sizes

What are suitable packaging solutions for animal drugs?

The veterinary pharmaceuticals market is regulated by government agencies such as the European Medicines Agency (EMA), USFDA (the US Food and Drug Administration), and others. These regulations affect the packaging as well: Stoelzle Pharma complies with the  European and US Pharmacopeia by using EcoSecur type 2 glass.

Moreover, Stoelzle Pharma produces high-end glass packaging in accordance with the ‘Good Manufacturing Practices GMP’ (ISO 15378). Hence, the highest hygiene and quality standards are met. Consequently, the primary packaging ensures the safety and purity of the contained pet medicine.

As the leading sustainable packaging material, Stoelzle’s glass containers are commonly applied for veterinary medicine products:

In fact, the broad range of primary glass packaging in amber and flint colour offer the suitable container for different animal drugs and vaccines. Aligned with our one-stop-shop mentality, we also offer caps and closures: From the matching aluminium crimp caps with rubber stoppers for our type 2 glass injection vials and infusion bottles to matching caps and closures for our type 3 glass.

Back to top ↑

Advantages of EcoSecur type 2 injection and infusion vials

Stoelzle Pharma has developed an innovative and resource-efficient process for the inner-surface treatment of type 2 glass containers. This progressive technique allows reliable and precise dosing tailored to each bottle size, which is especially crucial for the use of medication. The main advantages of EcoSecur type 2 injection vials and infusion bottles  are:

  • Process stability quality
  • Superior glass quality
  • Minimized environmental impact
  • Improved hydrolytic resistance

Discover our innovative EcoSecur type 2 glass product range and order the the sample box right here:

Order your sample box

Back to top ↑

Webinars by Stoelzle

Join our Expert Talks series and learn more about current and upcoming industry news.

Watch now

Thank you!

Your message has been sent.

You are subscribed to the Pharma Health & Safety Newsletter.

Your web browser (Internet Explorer) is out of date and should no longer be used for security reasons. Please install the current Microsoft browser (Microsoft Edge) to display this page correctly. Thank you!